DLL3 and melanoma: Substantiated investigations have elucidated that the downregulation of DLL3 can attenuate lipopolysaccharide-induced inflammation, inhibit migration, and impede invasion of melanoma cells through the inhibition of Twist1-mediated epithelial-mesenchymal transition63.